tiprankstipranks
Trending News
More News >
OrganiGram Holdings (TSE:OGI)
TSX:OGI
Canadian Market

OrganiGram Holdings (OGI) Earnings Dates, Call Summary & Reports

Compare
461 Followers

Earnings Data

Report Date
Jul 10, 2025
TBA Not Confirmed
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.01
Last Year’s EPS
0.03
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 12, 2025
|
% Change Since: 18.29%
|
Next Earnings Date:Jul 10, 2025
Earnings Call Sentiment|Positive
Organigram Global's earnings call revealed strong revenue performance and market leadership in Canada, driven by strategic acquisitions and international sales growth. However, there are challenges in penetrating the US market and navigating regulatory frameworks. The integration of recent acquisitions is showing positive synergies, and future growth is anticipated with strategic investments and market expansion.
Company Guidance
In the Organigram Global Second Quarter Fiscal 2025 earnings call, the company provided robust guidance, highlighting record-breaking performance and strategic growth initiatives. Organigram reported an impressive 74% year-over-year increase in net revenue, reaching $65.6 million, driven by the Motif acquisition and organic growth. The company maintained a strong presence in the Canadian cannabis market, holding a 21.7% market share in vapes, and saw international sales increase by 177% to $6.1 million. The Collective Project acquisition marked their entry into the US hemp-derived THC beverage market, with projections to grow this sector significantly. Organigram anticipates realizing $15 million in annual synergies from the Motif integration by next year and expects adjusted gross margins to stabilize around 35% for fiscal 2025, with a long-term target of 40% in the second half of fiscal 2026. Additionally, they are investing in capacity enhancements and innovative technology to further strengthen their market position and drive future growth.
Record-Breaking Revenue
Organigram Global reported a record-breaking quarter by revenue, with gross sales up 79% year-over-year, surpassing $100 million for the first time in any given quarter. Net revenue was up 74% year-over-year to reach $65.6 million.
Market Leadership in Canada
Organigram became the #1 LP by market share in both vapes and pre-rolls in Canada, with a leading 21.7% share in vapes. They have a strong presence in flower, vapes, and pre-rolls, representing around 85% of the total market.
International Sales Growth
International sales increased 177% year-over-year to $6.1 million, with growth driven by expanded orders from existing partners like Sanity Group and customers in Australia.
Successful Integration of Motif Acquisition
The integration of the Motif acquisition is progressing well, with operational efficiencies being realized, including increased extraction capacity and expected higher synergies than initially estimated.
Collective Project Expansion
Entry into the US hemp-derived THC beverage market with products distributed in 10 US states. The Collective Project brand won recognition at the 2025 High Spirits Awards.

OrganiGram Holdings (TSE:OGI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:OGI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 10, 2025
2025 (Q3)
-0.01 / -
0.028
May 12, 2025
2025 (Q2)
-0.04 / 0.32
-0.227240.97% (+0.55)
Feb 11, 2025
2025 (Q1)
-0.03 / -0.20
-0.175-14.29% (-0.03)
Dec 18, 2024
2024 (Q4)
-0.04 / -0.04
-0.40688.92% (+0.36)
Aug 13, 2024
2024 (Q3)
-0.07 / 0.03
-2.652101.06% (+2.68)
May 14, 2024
2024 (Q2)
-0.09 / -0.23
-0.084-170.24% (-0.14)
Feb 13, 2024
2024 (Q1)
-0.12 / -0.17
0.087-301.15% (-0.26)
Dec 19, 2023
2023 (Q4)
- / -0.41
0.087-566.67% (-0.49)
Jul 14, 2023
2023 (Q3)
-0.07 / -2.65
-0.032-8187.50% (-2.62)
Apr 11, 2023
2023 (Q2)
-0.08 / -0.08
-0.04-110.00% (-0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:OGI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 12, 2025
C$1.64C$1.80+9.76%
Feb 11, 2025
C$2.50C$2.06-17.60%
Dec 18, 2024
C$2.28C$2.10-7.89%
Aug 13, 2024
C$1.99C$2.49+25.13%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does OrganiGram Holdings (TSE:OGI) report earnings?
OrganiGram Holdings (TSE:OGI) is schdueled to report earning on Jul 10, 2025, TBA Not Confirmed.
    What is OrganiGram Holdings (TSE:OGI) earnings time?
    OrganiGram Holdings (TSE:OGI) earnings time is at Jul 10, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:OGI EPS forecast?
          TSE:OGI EPS forecast for the fiscal quarter 2025 (Q3) is -0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis